Reverse DCF implies just 4.41% growth forever, yet the stock trades 39% above fair value.
Zscaler embodies Mauboussin's classic expectations trap: the market prices in continued excellence while base rates and insider behavior signal mean reversion ahead.
What expectations are embedded in the price, and are they reasonable?
This framework suggests the market has dramatically lowered growth expectations from 23.9% to 4.41% perpetual, yet still pays a 39% premium to fair value. The muted 0.52% reaction to beats indicates perfection is already priced in, creating asymmetric downside risk.
Does this company have structural reasons to be an exception?
Applying this lens reveals a tension: exceptional pricing power (0.98 inflation correlation) exists alongside margin compression and persistent losses. Base rates suggest companies with negative margins at $2.67B scale rarely achieve sustained profitability without structural change.
Is the company creating or destroying value?
Without ROIC data, this framework examines cash generation efficiency. The 0.75% FCF yield at 90th percentile shows operational excellence, but 112% R&D reinvestment rate suggests the company consumes more capital than it generates for growth.
Has the market been right or wrong about this company?
This framework observes a striking divergence: analysts maintain unanimous optimism while insiders execute a 12-quarter selling streak. The wide target dispersion ($209-$360) and institutional distribution suggest the market's confidence may be misplaced.
Applying the Mauboussin framework reveals a classic expectations trap. While Zscaler demonstrates operational excellence with record FCF yields and perfect execution, the 39% valuation premium assumes this company defies base rates that predict margin compression and profitability challenges at scale. The 12-quarter insider selling streak suggests those with the most information see limited upside from here. Should investors bet against both base rates and insider judgment?
This analysis applies Michael Mauboussin's published investment framework to publicly available financial data. It is not authored by, endorsed by, or affiliated with Michael Mauboussin. Educational purposes only. Not financial advice.